Allogeneic mesenchymal stem cell therapy with laromestrocel in mild Alzheimer’s disease: a randomized controlled phase 2a trial

unknow

★ 5.0 · 45 reads

Sign in to save this
Request Code
ZLIB.IO18514120
Published
2022
Pages
1
Language
Unknown